| Reporting Period | Filing Date | Average Time to Pay (days) | Paid within 30 days | Paid 31-60 days | Paid after 60 days | Not Paid within Terms |
|---|---|---|---|---|---|---|
| 01 Jul 2025 - 31 Dec 2025 | 30 Jan 2026 | 95 | 23% | 27% | 50% | 72% |
| 01 Jan 2025 - 30 Jun 2025 | 06 Aug 2025 | 98 | 31% | 28% | 41% | 60% |
| 01 Jul 2024 - 31 Dec 2024 | 19 Feb 2025 | 97 | 40% | 20% | 40% | 55% |
| 01 Jan 2024 - 30 Jun 2024 | 31 Jul 2024 | 106 | 24% | 31% | 45% | 21% |
| 01 Jul 2023 - 31 Dec 2023 | 31 Jan 2024 | 34 | 57% | 32% | 11% | 41% |
| 01 Jan 2023 - 30 Jun 2023 | 20 Jul 2023 | 33 | 58% | 31% | 11% | 31% |
| 01 Jul 2021 - 31 Dec 2021 | 30 Jan 2022 | 43 | 38% | 50% | 13% | 64% |
| 01 Jan 2021 - 30 Jun 2021 | 29 Jul 2021 | 77 | 30% | 37% | 32% | 60% |
| 01 Jul 2020 - 31 Dec 2020 | 29 Jan 2021 | 90 | 31% | 27% | 42% | 70% |
| 01 Jan 2020 - 30 Jun 2020 | 30 Jul 2020 | 73 | 66% | 8% | 26% | 65% |
| 01 Jul 2019 - 31 Dec 2019 | 30 Jan 2020 | 48 | 53% | 27% | 21% | 36% |
| 01 Jan 2019 - 30 Jun 2019 | 24 Jul 2019 | 36 | 66% | 26% | 8% | 24% |
| 01 Jul 2018 - 31 Dec 2018 | 29 Jan 2019 | 32 | 77% | 17% | 6% | 17% |
| 01 Jan 2018 - 30 Jun 2018 | 30 Jul 2018 | 33 | 73% | 20% | 7% | 23% |
This information is as reported by the business, and responses are in their own words.
Standard payment terms
The default position is 90 days, however there may be changes to this default position on a case-by-case basis pending agreement with suppliers. On a case-by-case basis, payment terms to suppliers may be immediate payment or payment on terms within 7, 14, 30 or 60 days.
Were there any changes to the standard payment terms in the reporting period?
No information available
Any other information about payment terms
No additional information
Maximum contractual payment period agreed
90
If a supplier has a query or dispute relating to a payment they believe is owed to them by MMCL, the supplier is to email the below details to MMCL.APQueries@mundipharma.com: a. Full supplier name, address; b. The name of your MMCL point of contact; c. Invoice number for the payment you are querying; d. Full details of your complaint; e. Upon receipt of all of the above details, MMCL commits to acknowledge receipt of the supplier email within five working days, and may request further information to be able to respond in full. MMCL will investigate the supplier query using the details provided and speak with relevant members of MMCL’s business, including members of MMCL’s legal department if necessary, and respond in full within 14 days of the date of MMCL’s acknowledgement to the supplier.
Has this business signed up to a code of conduct or standards on payment practices?
For example, signatories to The Prompt Payment Code must commit to paying 95% of their invoices within 60 days.
❌
Does this business offer e-invoicing in relation to qualifying contracts?
This is where suppliers can electronically submit and track invoices. It's not just allowing suppliers to email them an invoice.
❌
Does this business offer supply chain finance?
This is where a supplier who has submitted an invoice can be paid by a third-party finance provider earlier than the agreed payment date. The business would then pay the finance provider the invoiced sum.
❌
Under its payment practices and policies, can this business deduct sums from payments under qualifying contracts as a charge for remaining on a supplier list?
❌
During the reporting period, did the business deduct sums from payments as a charge for remaining on a supplier list?
No information available
Mundipharma Medical Company Limited is registered in Cambridge and classified under wholesale of pharmaceutical goods. It forms part of Mundipharma, a global healthcare group focused on cancer pain management and specialty care, which develops and supplies medicines to healthcare practitioners, caregivers and patients worldwide. The group's UK operations, including this entity, are based at Cambridge Science Park, alongside related Mundipharma companies such as Napp Pharmaceuticals. While the wider group describes itself as a global organisation dedicated to patient care, collaboration and access to medicines, this particular registered company's role sits within that structure as a UK-based entity supporting the group's pharmaceutical supply activities.
Generated from the company's website and Companies House records. Sources: mundipharma.com · mundipharma.com · mundipharma.com